Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Delayed Quote USD

ScanSource, Inc. (SCSC)

Compare
32.15
+2.52
+(8.50%)
At close: April 9 at 4:00:03 PM EDT
31.86
-0.29
(-0.90%)
Pre-Market: 4:15:10 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 747.5M
Earnings 17.05M

Q1'24

Q2'24

Q3'24

Q4'24

0
200M
400M
600M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

46.00
50.50 Average
32.15 Current
55.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4444
Avg. Estimate 0.770.913.383.83
Low Estimate 0.660.843.293.6
High Estimate 0.910.973.573.92
Year Ago EPS 0.690.83.083.38

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3344
Avg. Estimate 809.17M842.8M3.14B3.34B
Low Estimate 760.9M805.1M3.02B3.19B
High Estimate 839.9M875M3.24B3.53B
Year Ago Sales 752.6M746.11M3.26B3.14B
Sales Growth (year/est) 7.52%12.96%-3.79%6.36%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 0.840.930.780.91
EPS Actual 0.690.80.840.85
Difference -0.15-0.130.06-0.06
Surprise % -17.53%-14.29%7.69%-6.25%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.770.913.383.83
7 Days Ago 0.770.913.383.83
30 Days Ago 0.810.93.413.8
60 Days Ago 0.820.933.563.87
90 Days Ago 0.820.933.563.87

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 2111
Up Last 30 Days 2111
Down Last 7 Days 1222
Down Last 30 Days 1222

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SCSC 12.32%13.75%9.74%13.24%
S&P 500 6.52%6.29%9.55%14.25%

Upgrades & Downgrades

Downgrade Raymond James: Outperform to Market Perform 8/15/2024
Downgrade Northcoast Research: Buy to Neutral 12/19/2023
Maintains Raymond James: Outperform to Outperform 11/10/2023
Upgrade Northcoast Research: Neutral to Buy 8/23/2023
Maintains Raymond James: Outperform 11/9/2022
Maintains Raymond James: Outperform 11/10/2021

Related Tickers